Diligence memo · auto-generated · as of July 3, 2026

Homeostasis Laboratories Inc

Homeostasis Laboratories Inc looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Homeostasis Laboratories Inc operates in Other Health Care, based in GREENWICH.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Homeostasis Laboratories Inc has raised $1.3M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $897K on 2009-11-25.

Most recent recorded round closed around 2011-01-24.

Valuation (modeled)modeled

Provath models Homeostasis Laboratories Inc at approximately $6.9M (range $141K–$79M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.75× the median modeled value of Pre-Seed Other Health Care companies in 2010–2012 (351 peers) — value vs value, same stage and era. Within the normal band (75% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 7 months.

Last raise 15.4 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.2× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 39% of Other Health Care peers (5377 compared).

Modeled value ranks above 27% of those peers.

Closest niche peers: Chrysallis, Inc., RefillDRS, LLC, Ageology LLC, Great Lakes Healthcare Fund I, LLC, CreateHealth, Inc..

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.